{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "PINK1",
        "Protein_Change": {
          "ref": "D",
          "alt": "D",
          "position": "309"
        },
        "variant_string_id": "PINK1 D309D"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The paper states that PINK1 is a Ser/Thr protein kinase targeted to mitochondria, and mutations in this gene are associated with recessive parkinsonism.",
          "judgment": "Yes",
          "reasoning": "The study explicitly links PINK1 mutations to recessive parkinsonism and describes its role in mitochondrial targeting and kinase activity."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The assay uses in vitro kinase activity and localization studies, which are standard techniques in the field.",
          "judgment": "Yes",
          "reasoning": "The use of kinase activity assays and mitochondrial localization studies aligns with established methods in PINK1 research."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Basic controls (wild-type and kinase-dead mutants) were used, and multiple replicates were performed.",
          "judgment": "Yes",
          "reasoning": "The assay included both wild-type and mutant controls, and replicates were reported, satisfying basic controls and replicates requirements."
        },
        {
          "step_name": "Step 3b: Accepted/validated assay",
          "extracted_paper_info": "The kinase activity assay is a standard technique in PINK1 research.",
          "judgment": "Yes",
          "reasoning": "The assay is broadly accepted in the field of mitochondrial protein kinases."
        },
        {
          "step_name": "Step 3c: Variant controls",
          "extracted_paper_info": "The G309D mutation was tested in the context of PINK1 function.",
          "judgment": "Yes",
          "reasoning": "The variant controls (wild-type and mutant) were used in the assay, and the variant's classification (likely pathogenic) is consistent with the study's findings."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "No explicit OddsPath calculation was provided, but the number of controls (10 or fewer) supports a strong assessment.",
          "judgment": "Yes",
          "reasoning": "With 10 or fewer controls, the evidence strength is Max PS3_supporting / Max BS3_supporting."
        }
      ],
      "evidence_strength": "PS3_supporting"
    },
    {
      "variant_id": {
        "Gene": "PINK1",
        "Protein_Change": {
          "ref": "P",
          "alt": "P",
          "position": "447"
        },
        "variant_string_id": "PINK1 P447P"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The paper states that L347P mutations significantly destabilize PINK1 function.",
          "judgment": "Yes",
          "reasoning": "The study explicitly links L347P mutations to reduced kinase activity and mitochondrial targeting."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The assay uses in vitro kinase activity and localization studies, which are standard techniques in the field.",
          "judgment": "Yes",
          "reasoning": "The use of kinase activity assays and mitochondrial localization studies aligns with established methods in PINK1 research."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Basic controls (wild-type and kinase-dead mutants) were used, and multiple replicates were performed.",
          "judgment": "Yes",
          "reasoning": "The assay included both wild-type and mutant controls, and replicates were reported, satisfying basic controls and replicates requirements."
        },
        {
          "step_name": "Step 3b: Accepted/validated assay",
          "extracted_paper_info": "The kinase activity assay is a standard technique in PINK1 research.",
          "judgment": "Yes",
          "reasoning": "The assay is broadly accepted in the field of mitochondrial protein kinases."
        },
        {
          "step_name": "Step 3c: Variant controls",
          "extracted_paper_info": "The L347P mutation was tested in the context of PINK1 function.",
          "judgment": "Yes",
          "reasoning": "The variant controls (wild-type and mutant) were used in the assay, and the variant's classification (likely pathogenic) is consistent with the study's findings."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "No explicit OddsPath calculation was provided, but the number of controls (10 or fewer) supports a strong assessment.",
          "judgment": "Yes",
          "reasoning": "With 10 or fewer controls, the evidence strength is Max PS3_supporting / Max BS3_supporting."
        }
      ],
      "evidence_strength": "PS3_moderate"
    }
  ]
}